U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Palmar hyperkeratosis

MedGen UID:
869284
Concept ID:
C4023710
Disease or Syndrome
Synonym: Hyperkeratosis, palmar
 
HPO: HP:0010765

Definition

Abnormal thickening of the skin localized to the palm of the hand. [from HPO]

Conditions with this feature

Wieacker-Wolff syndrome
MedGen UID:
163227
Concept ID:
C0796200
Disease or Syndrome
Wieacker-Wolff syndrome (WRWF) is a severe X-linked recessive neurodevelopmental disorder affecting the central and peripheral nervous systems. It is characterized by onset of muscle weakness in utero (fetal akinesia), which results in arthrogryposis multiplex congenita (AMC) apparent at birth. Affected boys are born with severe contractures, show delayed motor development, facial and bulbar weakness, characteristic dysmorphic facial features, and skeletal abnormalities, such as hip dislocation, scoliosis, and foot deformities. Additional features include global developmental delay with poor or absent speech and impaired intellectual development, feeding difficulties and poor growth, hypotonia, hypogenitalism, and spasticity. Carrier females may be unaffected or have mild features of the disorder (summary by Hirata et al., 2013 and Frints et al., 2019).
Epidermolytic palmoplantar keratoderma
MedGen UID:
354561
Concept ID:
C1721006
Disease or Syndrome
Epidermolytic palmoplantar keratoderma-1 (EPPK1) is an autosomal dominant skin disorder characterized clinically by diffuse, yellow thickening of the skin of the palms and soles. There is no extension of the keratoderma to dorsal surfaces of hands and feet, inner wrists, and Achilles tendon area (transgrediens). Knuckle pads may be present in some individuals (summary by Kuster et al., 2002, Chiu et al., 2007). Genetic Heterogeneity of Epidermolytic Palmoplantar Keratoderma Epidermolytic palmoplantar keratoderma-2 (EPPK2; 620411) is caused by mutation in the keratin-1 gene (KRT1; 139350) on chromosome 12q13. Classification of Palmoplantar Keratoderma PPK has been classified into diffuse, focal, and punctate forms according to the pattern of hyperkeratosis on the palms and soles (Lucker et al., 1994). Diffuse PPK develops at birth or shortly thereafter and involves the entire palm and sole with a sharp cutoff at an erythematous border; there are no lesions outside the volar skin, and, in particular, no follicular or oral lesions. In contrast, focal PPK is a late-onset form in which focal hyperkeratotic lesions develop in response to mechanical trauma; an important distinguishing feature is the presence of lesions at other body sites, e.g., oral and follicular hyperkeratosis (Stevens et al., 1996). Palmoplantar keratodermas can be further subdivided histologically into epidermolytic and nonepidermolytic PPK (Risk et al., 1994). Genetic Heterogeneity of Palmoplantar Keratoderma Nonepidermolytic palmoplantar keratoderma (NEPPK; 600962) is caused by mutation in the KRT1 gene. A focal form of NEPPK (FNEPPK1; 613000) is caused by mutation in the KRT16 gene (148067). Another focal form, FNEPPK2 (616400), is caused by mutation in the TRPV3 gene (607066); mutation in TRPV3 can also cause Olmsted syndrome (OLMS; 614594), a severe mutilating form of PPK. The diffuse Bothnian form of NEPPK (PPKB; 600231) is caused by mutation in the AQP5 gene (600442). The Nagashima type of nonepidermolytic diffuse PPK (PPKN; 615598) is caused by mutation in the SERPINB7 gene (603357). A generalized form of epidermolytic hyperkeratosis (EHK; 113800), also designated bullous congenital ichthyosiform erythroderma (BCIE), is caused by mutation in the keratin genes KRT1 and KRT10 (148080). For a discussion of punctate PPK, see 148600; for a discussion of striate PPK, see 148700.
Tooth agenesis, selective, 4
MedGen UID:
372057
Concept ID:
C1835492
Disease or Syndrome
Any tooth agenesis in which the cause of the disease is a mutation in the WNT10A gene.
Adermatoglyphia
MedGen UID:
338875
Concept ID:
C1852150
Finding
Isolated congenital adermatoglyphia is a rare, genetic developmental defect during embryogenesis disorder characterized by the lack of epidermal ridges on the palms and soles, resulting in the absence of fingerprints, with no other associated manifestations. It is associated with a reduced number of sweat gland openings and reduced transpiration of palms and soles.
Ectodermal dysplasia-syndactyly syndrome 1
MedGen UID:
462157
Concept ID:
C3150807
Disease or Syndrome
Ectodermal dysplasia-syndactyly syndrome (EDSS) is characterized by sparse to absent scalp hair, eyebrows, and eyelashes, hypoplastic nails, tooth enamel hypoplasia, conical-shaped teeth, palmoplantar keratoderma, and partial cutaneous syndactyly (summary by Raza et al., 2015). Genetic Heterogeneity of Ectodermal Dysplasia-Syndactyly Syndrome Ectodermal dysplasia-syndactyly syndrome-2 (EDSS2; 613576) maps to chromosome 7p21-p14.
Pachyonychia congenita 3
MedGen UID:
811523
Concept ID:
C3714948
Disease or Syndrome
Pachyonychia congenita (PC) is characterized by hypertrophic nail dystrophy, painful palmoplantar keratoderma and blistering, oral leukokeratosis, pilosebaceous cysts (including steatocystoma and vellus hair cysts), palmoplantar hyperhydrosis, and follicular keratoses on the trunk and extremities.

Professional guidelines

PubMed

Kodali N, Patel VM, Schwartz RA
Ital J Dermatol Venerol 2023 Jun;158(3):217-223. Epub 2023 May 11 doi: 10.23736/S2784-8671.23.07594-1. PMID: 37166753
Porter RM, Bravo AA, Smith FJD
J Am Podiatr Med Assoc 2017 Sep;107(5):428-435. doi: 10.7547/16-043. PMID: 29077501
Shwayder T
Am J Clin Dermatol 2004;5(1):17-29. doi: 10.2165/00128071-200405010-00004. PMID: 14979740

Recent clinical studies

Etiology

Laraqui O, Manar N, Laraqui S, Ghailan T, Deschamps F, Hammouda R, Laraqui CEH
Int Marit Health 2018;69(1):22-27. doi: 10.5603/IMH.2018.0004. PMID: 29611610
Wachtel TJ
Int J Dermatol 1981 May;20(4):270-1. doi: 10.1111/j.1365-4362.1981.tb04335.x. PMID: 7239745

Diagnosis

Pérez-López I, Herrera-García JD, Ruiz-Villaverde R
Med Clin (Barc) 2020 Sep 25;155(6):279. Epub 2019 Sep 7 doi: 10.1016/j.medcli.2019.07.009. PMID: 31506202
Yang YH, Zhang RZ, Kang DH, Zhu WY
Dermatol Online J 2013 Jul 14;19(7):18966. PMID: 24010512
Pilger U, Hennies HC, Truschnegg A, Aberer E
J Am Acad Dermatol 2003 Nov;49(5 Suppl):S240-3. doi: 10.1016/s0190-9622(03)01558-5. PMID: 14576640
Bonkowsky JL, Johnson J, Carey JC, Smith AG, Swoboda KJ
Pediatrics 2003 Sep;112(3 Pt 1):e237-41. doi: 10.1542/peds.112.3.e237. PMID: 12949319
Kurzrock R, Cohen PR
Am J Med 1995 Dec;99(6):662-71. doi: 10.1016/s0002-9343(99)80254-x. PMID: 7503090

Therapy

Demirci U, Coskun U, Erdem O, Ozturk B, Bilge Yilmaz I, Benekli M, Buyukberber S
J Oncol Pharm Pract 2011 Sep;17(3):285-7. Epub 2010 Jun 15 doi: 10.1177/1078155210374674. PMID: 20551113
French D, Scott H, Overall CM
J Can Dent Assoc 1995 May;61(5):432-8. PMID: 7773869
Bruzzone M, Conte PF, Chiara S, Carnino F, Giaccone G, Conio A, Bentivoglio G, Pescetto G, Rosso R
Chemioterapia 1985 Apr;4(2):139-42. PMID: 3891114
Hutton JT, Christians BL
J Fam Pract 1983 Sep;17(3):423-6. PMID: 6886645
Wachtel TJ
Int J Dermatol 1981 May;20(4):270-1. doi: 10.1111/j.1365-4362.1981.tb04335.x. PMID: 7239745

Prognosis

Kurzrock R, Cohen PR
Am J Med 1995 Dec;99(6):662-71. doi: 10.1016/s0002-9343(99)80254-x. PMID: 7503090

Clinical prediction guides

Yang YH, Zhang RZ, Kang DH, Zhu WY
Dermatol Online J 2013 Jul 14;19(7):18966. PMID: 24010512
Kolde G, Hennies HC, Bethke G, Reichart PA
J Am Acad Dermatol 2005 Mar;52(3 Pt 1):403-9. doi: 10.1016/j.jaad.2004.07.029. PMID: 15761417
Wachtel TJ
Int J Dermatol 1981 May;20(4):270-1. doi: 10.1111/j.1365-4362.1981.tb04335.x. PMID: 7239745

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...